Biography
- Lina Jandorf is the Director of Cancer Community Outreach in the Department of Oncological Sciences as well as the Director of Minority, Outreach, Recruitment and Education (MORE) for the Tisch Cancer Institute. Working with community agencies and health organizations, Ms. Jandorf is responsible for bringing cancer education and screening programs to medically underserved communities and recruiting minority residents into our research efforts. One early outcome of this work was the funding, by the National Cancer Institute, of a five year grant to develop the East Harlem Partnership for Cancer Awareness, a coalition of hospitals, community health centers, and community agencies with the common goal of increasing cancer awareness and thereby preventive care in East Harlem. In addition, Ms. Jandorf has been funded to establish the Witness Project of Harlem, a faith-based breast and cervical education program targeting African American women and Esperanza y Vida, a faith-based breast and cervical education program for Latino families. Ms. Jandorf is an active member of New York State’s Cancer Consortium Steering Comnittee and a member of the steering committee for New York City’s Citywide Colon Cancer Control Coalition.
Recently, with others in the Department of Oncological Services and with Steven Itzkowitz, M.D. (Division of Gastroenterology) she has developed a patient navigation program to increase adherence to physician recommended screening colonoscopies. These National Cancer Institute funded projects test different forms of navigation guidance through the medical system including peer navigators (community volunteers) who themselves have completed a colonoscopy.
Ms. Jandorf has also taken the lead in the Department of Oncological Sciences effort to establish Cancer Family Registries. These databases, specific to cancer site, include both index patients and family members. They allow us to establish the relative risk of various cancers and related disorders. In addition, the registries include information about medical practices, family history, nutrition, recreational activities, and exercise.
Ms. Jandorf also directs a number of clinical initiatives, funded through the Division of Gastroenterology (Steven Itzkowitz, M.D.), exploring new, less invasive ways to screen for colorectal cancer. These include stool-based methodologies for both average risk individuals and those at higher risk due related to Irritable Bowel Disorders (Ulcerative Colitis and Crohn's Disease).
Research and Outreach Programs
Please visit Ms. Jandorf’s Laboratory Page for descriptions of her different Research and Outreach Programs.
·Improving CRC Screening for Diverse Hispanics in an Urban
Primary Care Setting
· Enhanced Patient Navigation for Screening Colonoscopy in East Harlem Residents
· Patient Navigation for Colorectal Cancer Screening with Low-Income Minorities
· Assessment of Barriers and Facilitators to Participating in Cancer Clinical
Trials Among Cancer Patients
·Minority Outreach, Recruitment and Education Core (MORE)
· The Witness Project® of Harlem
· Esperanza y Vida® - The Latina Witness Project of Harlem
· Hope and Life®
Research
Cancer Education and Prevention
Lina Jandorf’s research efforts are focused on reducing disparities in cancer screening, early detection, and mortality. This work has been focused on understanding cultural, interpersonal and organizational barriers to cancer screening as well as important association between health disparities and mortality and morbidity. Through the use of Lay Health Workers, her research focuses on the development and implementation of culturally and linguistically appropriate interventions to support and encourage cancer screening for medically underserved individuals. Ms. Jandorf also directs a number of clinical initiatives, funded through the Division of Gastroenterology (Steven Itzkowitz, M.D.), exploring new, less invasive ways to screen for colorectal cancer. These include stool-based methodologies for both average risk individuals and those at higher risk due related to Irritable Bowel Disorders (Ulcerative Colitis and Crohn's Disease).Publications
Jandorf L, Chang MS, Smith K, Florio A, Hall SJ. Community Based Free Prostate Cancer Screening Program. Progress in Community Health Partnerships 2007; 1(3): 215-220.
Christie J, Itzkowitz S, Lihau-Nkanza I, Castillo A, Redd W, Jandorf LA. A Randomized Controlled Trial Using Patient Navigation to Increase Colonoscopy Screening among Low-Income Minorities. Journal of the National Medical Association 2007; 100(3): 1-7.
Rini C, Jandorf L, Valdimarsdottir H, Brown K, Itzkowitz SH. Distress among Inflammatory Bowel Disease Patients at High Risk for Colorectal Cancer: a preliminary investigation of the effects of family history of cancer, disease duration, and perceived social support. Psycho-Oncology 2007 July 2; 17(4): 354-62.
Chen L, Santos S, Jandorf L, Christie J, Castillo A, Winkel G, Itzkowitz S. Program to Enhance Completion of Screening Colonoscopy Completion Among Urban Minorities. Clinical Gastroenterology and Hepatology 2008; 6(4): 443-450.
Edwards TA, Thompson HS, Kwate NA, Brown K, McGovern MM, Forman A, Kapil-Pair N, Jandorf L, Bovbjerg DH, Valdimarsdottir HB. Association between temporal orientation and attitudes about BRCA1/2 testing among women of African descent with family histories of breast cancer. Patient Education and Counseling 2008; 72(2): 276-82.
Jandorf L, Bursac Z, Pulley L, Trevino M, Castillo A, Erwin DO. Breast and Cervical Cancer Screening among Latinas Attending Culturally Specific Educational Programs. Progress in Community Health Partnerships: Research, Education and Action 2008; 2(3): 195-204.
Fatone AM, Jandorf L. Predictors of Cervical Cancer Screening among Urban African Americans and Latinas. American Journal of Health Behavior 2009; 33(4): 416-24.
Sussner KM, Thompson HS, Valdimarsdottir HB, Redd WH, Jandorf L. Acculturation and familiarity, attitudes and beliefs about genetic testing for cancer risk within Latinas in East Harlem, New York City. Journal of Urban Health 2009; 18(1): 60-71.
Itzkowitz SH, Brand R, Jandorf L, Durkee K, Millholland J, Rabeneck L, Schroy PC III, Sontag S, Johnson D, Markowitz S, Paszat L, Barry BM. A Simplified, Non-Invasive Stool DNA Test for Colorectal Cancer Detection. American Journal of Gastroenterology 2008; 103: 1-9.
Jandorf L, Fatone A, Borker PV, Levin M, Esmond WA, Brenner B, Butts G, Redd WH. Creating alliances to improve cancer prevention and detection among urban medically underserved minority groups. The East Harlem Partnership for Cancer Awareness. Cancer 2006 Oct; 107(8 Suppl).
Jandorf L, Ellison J, Villagra C, Winkel G, Varela A, Quintero-Canetti Z, Castillo A, Thélémaque L, King S, Duhamel K. Understanding the barriers and facilitators of colorectal cancer screening among low income immigrant hispanics. Journal of immigrant and minority health / Center for Minority Public Health 2010 Aug; 12(4).
Jandorf L, Ellison J, Shelton R, Thélémaque L, Castillo A, Mendez EI, Horowitz C, Treviño M, Doty B, Hannigan M, Aguirre E, Harfouche-Saad F, Colon J, Matos J, Pully L, Bursac Z, Erwin DO. Esperanza y Vida: a culturally and linguistically customized breast and cervical education program for diverse Latinas at three different United States sites. Journal of health communication 2012; 17(2).
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Jandorf did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Icahn Medical Institute Floor 2nd Fl Room Room 2-70
1425 Madison Avenue
New York, NY 10029
Fax: 212-849-2566
